Medpace Holdings, Inc.

Global CRO providing full-service clinical development to biotech, pharma & medical device industries.

MEDP | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 5375 MEDPACE WAY, 45227 CINCINNATI
Website:: https://investor.medpace.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO). It provides comprehensive Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company's mission is to accelerate the development of safe and effective medical therapeutics through a disciplined operating approach. Key services include study strategy, clinical trial management, regulatory support, data management, and integrated laboratory services such as central lab, bioanalytical, ECG, and imaging core labs. Medpace leverages therapeutic expertise across major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system (CNS), and anti-viral/anti-infective diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Medpace Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medpace Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Medpace Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Developing a CIZ1B biomarker blood test for the early detection of lung cancer.	United Kingdom	CIZ
Clear Channel Outdoor Holdings, Inc. An OOH ad platform connecting brands to consumers via digital billboards and data analytics.	United States of America	CCO
CODEXIS, INC. Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.	United States of America	CDXS
Cogent Biosciences, Inc. Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.	United States of America	COGT
COMPASS Pathways plc Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.	United States of America	CMPS
COMSCORE, INC. Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.	United States of America	SCOR
COPRO-HOLDINGS. Co., Ltd. Dispatches technical personnel to Japan's construction & plant industries.	Japan	7059
Corbus Pharmaceuticals Holdings, Inc. Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.	United States of America	CRBP
Corvus Pharmaceuticals, Inc. Develops novel, targeted therapies for immune diseases and cancer.	United States of America	CRVS
Coya Therapeutics, Inc. Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.	United States of America	COYA